Physician

Richard Robert Bayer, M.D.

According to 2025 Medicare claims, Richard Bayer, M.D. (NPI: 1336346527) practices cardiology in the Billings, MT market, with the plurality of this provider's patient population coming from Yellowstone, MT. This provider's primary affiliated billing organization is SCL HEALTH MEDICAL GROUP - BILLINGS LLC (NPI: 1508289703; TIN: 464056262) and primary practice location at 59101-7502. Bayer is affiliated with the Rocky Mountain Accountable Health Network, Inc (ACO ID: A2217) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Bayer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,816 traditional Medicare patients, billed 6,653 HCPCS/CPT codes, and received $179,250 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 2,042 prescription claims across 368 beneficiaries totaling $338,292 in drug costs, led by Eliquis (Apixaban). 2015 DME data shows 44 claims. Open Payments data shows 3 records totaling $48. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $95,810 to $338,292. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,587	2,737	$138,847
2016	2,363	4,249	$173,283
2017	2,773	5,066	$195,354
2018	3,021	5,218	$190,614
2019	3,151	5,207	$180,744
2020	2,779	4,421	$156,751
2021	2,166	3,603	$124,240
2022	1,302	3,247	$143,382
2023	2,805	6,403	$151,026
2024	2,816	6,653	$179,250

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	225	1,813	$95,810
2016	270	2,457	$107,618
2017	325	2,760	$142,302
2018	336	2,689	$180,369
2019	324	2,245	$150,229
2020	288	1,922	$227,501
2021	264	1,575	$199,238
2022	318	1,228	$166,927
2023	327	1,757	$332,324
2024	368	2,042	$338,292

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	44	$3,845
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	493	503	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	236	306	$91
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	159	159	$55
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	305	315	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,962	3,182	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	157	7,066	$131,152
Jardiance	Empagliflozin	67	3,230	$63,077
Xarelto	Rivaroxaban	45	2,349	$45,789
Entresto	Sacubitril/Valsartan	46	2,135	$44,409
Metoprolol Succinate	Metoprolol Succinate	295	23,924	$4,897

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$48	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard Robert Bayer, M.D.?

Tedicare shows public-source Medicare data for Richard Robert Bayer, M.D. (NPI 1336346527), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard Robert Bayer, M.D. have ACO affiliation data?

Richard Robert Bayer, M.D. is shown with ACO affiliation data for Rocky Mountain Accountable Health Network, Inc (MSSP, ACO ID A2217) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Richard Robert Bayer, M.D.?

Richard Robert Bayer, M.D. is linked to SCL HEALTH MEDICAL GROUP - BILLINGS LLC (billing NPI 1508289703) in the available physician profile data.

Does Richard Robert Bayer, M.D. have Open Payments data?

Richard Robert Bayer, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.